Inter and intrapatient evolution of hepatitis C virus

被引:10
作者
Di Lillo, Federico A. [1 ]
Culasso, Andres C. A.
Campos, Rodolfo H.
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1053 Buenos Aires, DF, Argentina
关键词
HCV; Quasispecies; Liver disease; HIV-INFECTED PATIENTS; QUASI-SPECIES VARIABILITY; SPONTANEOUS CLEARANCE; PEGYLATED INTERFERON; PLUS RIBAVIRIN; VIROLOGICAL RESPONSE; ANTIVIRAL THERAPY; GENETIC-VARIATION; CLASS-I; HCV;
D O I
10.1016/S1665-2681(19)31164-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population sizes, all of which make it an excellent experimental model for evolution studies, because evolution can be visualized in real-time. In this review, we discuss the implications to study HCV evolution at the interpatient and intrapatient levels of infection. The HCV interpatient dynamics is relatively slow, because the generation time is generally long. Then, at population level, the HCV diversity originated by the high mutation and replication rates is modulated by the bottleneck at transmission. Thus, when the virus is transmitted to other hosts, viral diversity is reduced as a result of the founder effect. On the other hand, during intrapatient infection, HCV evolves rapidly, resulting in quasispecies. Accumulated evidence suggests that this quasispecies composition of the HCV population within the same individual may allow the virus to evade the immune response or escape treatment, leading to chronic infection. Thus, a better understanding of the complexities underlying the molecular evolution of HCV in natural populations is needed before accurate predictions of viral evolution can be made. In summary, HCV evolves both within and among patients. Consequently, HCV evolution should be studied at both levels in order to better understand the natural history of the virus and its potential implications in epidemiology, outcome of infection and progression of liver disease.
引用
收藏
页码:442 / 449
页数:8
相关论文
共 76 条
  • [1] A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants
    Adiwijaya, Bambang S.
    Herrmann, Eva
    Hare, Brian
    Kieffer, Tara
    Lin, Chao
    Kwong, Ann D.
    Garg, Varun
    Randle, John C. R.
    Sarrazin, Christoph
    Zeuzem, Stefan
    Caron, Paul R.
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2010, 6 (04)
  • [2] Intra-host evolutionary dynamics of hepatitis C virus E2 in treated patients
    Alfonso, V
    Mbayed, VA
    Sookoian, S
    Campos, RH
    [J]. JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 2781 - 2786
  • [3] Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection
    Alfonso, V
    Flichman, DM
    Sookoian, S
    Mbayed, VA
    Campos, RH
    [J]. JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 39 - 46
  • [4] Epidemiology of hepatitis C virus infection
    Alter, Miriam J.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (17) : 2436 - 2441
  • [5] [Anonymous], JAMA
  • [6] Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment
    Bartels, Doug J.
    Sullivan, James C.
    Zhang, Eileen Z.
    Tigges, Ann M.
    Dorrian, Jennifer L.
    De Meyer, Sandra
    Takemoto, Darin
    Dondero, Elizabeth
    Kwong, Ann D.
    Picchio, Gaston
    Kieffer, Tara L.
    [J]. JOURNAL OF VIROLOGY, 2013, 87 (03) : 1544 - 1553
  • [7] Viral mutation and substitution: units and levels
    Belshaw, Robert
    Sanjuan, Rafael
    Pybus, Oliver G.
    [J]. CURRENT OPINION IN VIROLOGY, 2011, 1 (05) : 430 - 435
  • [8] GENETIC-HETEROGENEITY OF HEPATITIS-C VIRUS - QUASI-SPECIES AND GENOTYPES
    BUKH, J
    MILLER, RH
    PURCELL, RH
    [J]. SEMINARS IN LIVER DISEASE, 1995, 15 (01) : 41 - 63
  • [9] Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1
    Canobio, S
    Guilbert, CM
    Troesch, M
    Samson, J
    Lemay, M
    Pelletier, VA
    Bernard-Bonnin, AC
    Kozielski, R
    Lapointe, N
    Martin, SR
    Soudeyns, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (09) : 4365 - 4369
  • [10] Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection
    Chambers, TJ
    Fan, XF
    Droll, DA
    Hembrador, E
    Slater, T
    Nickells, MW
    Dustin, LB
    DiBisceglie, AM
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (05) : 3071 - 3083